For Indian CDMOs, the opportunity is to build depth rather than pursue growth through capacity alone. At Biodeal, our ...

The launch builds on AHH's cumulative investment of Rs 650 crore in AINU, with a further Rs 100 crore committed towards the ...

Docterz, a Mumbai-based healthcare technology company founded by practising paediatrician Dr Atish Laddad, has raised Rs 5 crore from approximately 35 investors. Nearly 60% of the funding—close to Rs ...

Case taking continues after the patient's initial account has been recorded. A doctor may need to clarify when a symptom began or return to a reference after new information emerges. If a symptom ...

Pune-based health-tech startup, Clinics On Cloud has secured $12.5 million in Series A funding from Dubai-based investors ...

Thyrocare Technologies has entered the pregnancy testing segment with the launch of the Thyrocare Pregnancy Kit, the first ...

The Union Ministry of Health and Family Welfare has proposed an amendment to Rule 43A of the 'Drugs Rules, 1945'. The ...

Shilpa CDMO is investing $50 million to expand its peptide manufacturing capabilities as global demand accelerates for GLP-1s and a new generation of more complex peptide therapeutics.

Phatebo is a licensed pharmaceutical company based in Hilzingen, Germany, specialising in clinical trial supply, with revenues of approximately Rs 350 crore in 2025. The terms of the transaction were ...

Zydus launched its semaglutide brands, co-marketed with Lupin, and its own AI-enabled CGMs, Diasens and GlucoLive, with ...

The affordability of medicines in India has come under renewed scrutiny after the Supreme Court (SC) questioned the wide gap ...

A key priority is to look beyond the cost of medicines and strengthen the entire oncology-care pathway, particularly ...